AURA BIOSCIENCES, INC.

NASDAQ:AURA
Annual Meeting

of Shareholders

MEETING DATE

08/05/2026
DEF 14A FILED
06/29/2026
PUBLISHED
06/29/2026 9:28 pm
TIME TO PUBLISH
07/01/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:AURA · CUSIP

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

2
FOR
0
AGAINST
0
WITHHOLD
2
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Approval of an amendment to our Tenth Amended and Restated Certificate of Incorporation to increase authorized shares of common stock from 150,000,000 to 500,000,000
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

Filing states additional authorized shares would provide flexibility for corporate purposes.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Approval of Amendment No. 1 to the Aura Biosciences, Inc. 2021 Stock Option and Incentive Plan
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

Filing states equity grants help attract and retain talented individuals.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

03e185d7aed4542a601c3c6ae5b9226414dbbbec6e4f9493a7fabf2b97429489

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates